 |
|
Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection
Won Gil Chung, Hong Joo Kim, Young Gil Choe, Hyo Sun Seok, Chang Wook Chon, Yong Kyun Cho, Byung Ik Kim, Young Yool Koh
Clin Mol Hepatol. 2012;18(2):195-202. Published online 2012 Jun 26 DOI: https://doi.org/10.3350/cmh.2012.18.2.195
|
|
Citations to this article as recorded by
 The co-existence of NAFLD and CHB is associated with suboptimal viral and biochemical response to CHB antiviral therapy: a systematic review and meta-analysis
Georgia Zeng, Benjamin R. Holmes, Saleh A. Alqahtani, Upkar S. Gill, Patrick T. F. Kennedy
Frontiers in Gastroenterology.2024;[Epub] CrossRef KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology.2022; 28(2): 276. CrossRef Alcohol Intake and Mortality in Patients With Chronic Viral Hepatitis: A Nationwide Cohort Study
Dong Hyun Sinn, Danbee Kang, Eliseo Guallar, Yoosoo Chang, Seungho Ryu, Di Zhao, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
American Journal of Gastroenterology.2021; 116(2): 329. CrossRef Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment
Ya‐Chao Tao, Meng‐Lan Wang, Dong‐Mei Zhang, Dong‐Bo Wu, Yong‐Hong Wang, Juan Liao, Hong Tang, En‐Qiang Chen
Journal of Viral Hepatitis.2020; 27(7): 731. CrossRef Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective study
Yi-Cheng Chen, Wen-Juei Jeng, Chao-Wei Hsu, Chun-Yen Lin
BMC Gastroenterology.2020;[Epub] CrossRef KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology.2019; 25(2): 93. CrossRef Natural History and Treatment Indications of Chronic Hepatitis B
Dong Hyun Sinn
The Korean Journal of Gastroenterology.2019; 74(5): 245. CrossRef Effect of Metabolic Syndrome on the Clinical Outcomes of Chronic Hepatitis B Patients with Nucleos(t)ide Analogues Treatment
Nam Hee Kim, Yong Kyun Cho, Byung Ik Kim, Hong Joo Kim
Digestive Diseases and Sciences.2018; 63(10): 2792. CrossRef Hepatitis B virus infection and alcohol consumption
Ayako Iida-Ueno, Masaru Enomoto, Akihiro Tamori, Norifumi Kawada
World Journal of Gastroenterology.2017; 23(15): 2651. CrossRef Emerging concepts in alcoholic hepatitis
Phoenix Fung, Nikolaos Pyrsopoulos
World Journal of Hepatology.2017; 9(12): 567. CrossRef Interaction of obesity and infections
N. V. Dhurandhar, D. Bailey, D. Thomas
Obesity Reviews.2015; 16(12): 1017. CrossRef Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B
J. C. Hsiang, G. L.‐H. Wong, H. L.‐Y. Chan, A. W.‐H. Chan, A. M.‐L. Chim, V. W.‐S. Wong
Alimentary Pharmacology & Therapeutics.2014; 40(6): 716. CrossRef
|